These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15544433)

  • 21. Genomics and systems biology--how relevant are the developments to veterinary pharmacology, toxicology and therapeutics?
    Witkamp RF
    J Vet Pharmacol Ther; 2005 Jun; 28(3):235-45. PubMed ID: 15953196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabonomics: a useful tool for the future surgeon.
    Goldsmith P; Fenton H; Morris-Stiff G; Ahmad N; Fisher J; Prasad KR
    J Surg Res; 2010 May; 160(1):122-32. PubMed ID: 19592031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of end points relevant to detection of potentially adverse drug reactions.
    Hellmold H; Nilsson CB; Schuppe-Koistinen I; Kenne K; Wärngård L
    Toxicol Lett; 2002 Feb; 127(1-3):239-43. PubMed ID: 12052663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicogenomic approach for assessing toxicant-related disease.
    Waters MD; Olden K; Tennant RW
    Mutat Res; 2003 Nov; 544(2-3):415-24. PubMed ID: 14644344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity.
    Guleria A; Kumar A; Kumar U; Raj R; Kumar D
    Curr Top Med Chem; 2018; 18(20):1827-1849. PubMed ID: 30465509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of toxicogenomics.
    Hamadeh HK; Amin RP; Paules RS; Afshari CA
    Curr Issues Mol Biol; 2002 Apr; 4(2):45-56. PubMed ID: 11931569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabonomics: a platform for studying drug toxicity and gene function.
    Nicholson JK; Connelly J; Lindon JC; Holmes E
    Nat Rev Drug Discov; 2002 Feb; 1(2):153-61. PubMed ID: 12120097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo toxicity screening programs using metabonomics.
    Robosky LC; Robertson DG; Baker JD; Rane S; Reily MD
    Comb Chem High Throughput Screen; 2002 Dec; 5(8):651-62. PubMed ID: 12470262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis.
    Lindon JC; Holmes E; Bollard ME; Stanley EG; Nicholson JK
    Biomarkers; 2004; 9(1):1-31. PubMed ID: 15204308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?
    Griffin JL
    Philos Trans R Soc Lond B Biol Sci; 2006 Jan; 361(1465):147-61. PubMed ID: 16553314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements.
    Lindon JC; Keun HC; Ebbels TM; Pearce JM; Holmes E; Nicholson JK
    Pharmacogenomics; 2005 Oct; 6(7):691-9. PubMed ID: 16207146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabonomic applications in toxicity screening and disease diagnosis.
    Shockcor JP; Holmes E
    Curr Top Med Chem; 2002 Jan; 2(1):35-51. PubMed ID: 11899064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The potential of metabonomics in drug safety and toxicology.
    Griffin JL
    Drug Discov Today Technol; 2004 Dec; 1(3):285-93. PubMed ID: 24981497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. State-of-the-art genomics approaches in toxicology.
    Van Hummelen P; Sasaki J
    Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Future of toxicology--low-dose toxicology and risk--benefit analysis.
    Rietjens IM; Alink GM
    Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive summary--Predict-IV: A systems toxicology approach to improve pharmaceutical drug safety testing.
    Mueller SO; Dekant W; Jennings P; Testai E; Bois F
    Toxicol In Vitro; 2015 Dec; 30(1 Pt A):4-6. PubMed ID: 25450741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug metabolite profiling and elucidation of drug-induced hepatotoxicity.
    Tang W
    Expert Opin Drug Metab Toxicol; 2007 Jun; 3(3):407-20. PubMed ID: 17539747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro human hepatocyte-based experimental systems for the evaluation of human drug metabolism, drug-drug interactions, and drug toxicity in drug development.
    Li AP
    Curr Top Med Chem; 2014; 14(11):1325-38. PubMed ID: 24805059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data.
    Nicholson JK; Lindon JC; Holmes E
    Xenobiotica; 1999 Nov; 29(11):1181-9. PubMed ID: 10598751
    [No Abstract]   [Full Text] [Related]  

  • 40. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks.
    Holmes E; Nicholson JK; Tranter G
    Chem Res Toxicol; 2001 Feb; 14(2):182-91. PubMed ID: 11258967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.